Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s stock price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.77 and traded as low as $0.17. Arch Therapeutics shares last traded at $0.51, with a volume of 3,432 shares trading hands.
Arch Therapeutics Trading Down 9.3 %
The company has a fifty day moving average price of $0.77 and a two-hundred day moving average price of $1.24.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last announced its quarterly earnings results on Monday, August 19th. The biotechnology company reported ($1.44) earnings per share for the quarter. The business had revenue of $0.03 million for the quarter.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
See Also
- Five stocks we like better than Arch Therapeutics
- P/E Ratio Calculation: How to Assess Stocks
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- About the Markup Calculator
- Introduction to Fibonacci Retracement Levels
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
